[{"Assets_0_Q3_USD":514984000.0,"CommonStockSharesOutstanding_0_Q3_shares":35704000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":108788000.0,"NetIncomeLoss_1_Q3_USD":-19202000.0,"NetIncomeLoss_3_Q3_USD":95631000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":33988000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":35875000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":33988000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":32576000.0,"StockholdersEquity_0_Q3_USD":494057000.0,"EarningsPerShareBasic_1_Q3_USD":-0.56,"EarningsPerShareBasic_3_Q3_USD":2.94,"EarningsPerShareDiluted_1_Q3_USD":-0.56,"EarningsPerShareDiluted_3_Q3_USD":2.67,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":5306000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":177728000.0,"Ticker":"RGNX","CIK":"1590877","name":"REGENXBIO INC.","OfficialName":"REGENXBIO Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1299022052.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20181107"}]